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Abstract 
Aim: Irritable Bowel Syndrome (IBS) is a chronic functional bowel condition, which has 
substantial impact on quality of life and use of healthcare services. Patients often report using 
complementary and alternative medicine (CAM) for symptom management despite limited 
evidence to support its use. Psychological factors have been shown to be important in both 
influencing CAM use and as avenues of intervention to assist in managing IBS symptoms.  
Therefore, this review assessed prevalence of and psychological factors associated with CAM 
use by people with IBS. Method: Five electronic databases (including AMED, EMBASE and 
PsychINFO) were searched for studies that examined both the extent of and the reasons for 
CAM use. Five studies met the inclusion criteria. Results: Prevalence of CAM use ranged 
from 9% to 38%. CAM use was associated with psychosocial factors, including concerns 
about conventional medical care (i.e. the perceived harmful effects of medication, perception 
that conventional medicine had failed, and lack of satisfaction with conventional care) and 
anxiety. Conclusion: These findings identify psychological factors associated with CAM use 
which could be targeted through psychologically oriented management strategies for those 
affected with IBS.   
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Introduction 
Irritable bowel syndrome (IBS) is a chronic functional bowel disorder characterised by 
numerous episodic symptoms including abdominal pain, constipation, diarrhoea, and 
abdominal bloating. Prevalence estimates range from 7 to 20% in western populations 
(Andrews et al., 2005; Grundmann & Yoon, 2010) with reported female predominance in 
healthcare seeking (Andrews et al., 2005; Hungin, Chang, Locke, Dennis, & Barghout, 2005; 
Wilson, Roberts, Roalfe, Bridge, & Singh, 2004). Many affected are frequent users of 
healthcare services (Talley, 2008) and may be referred for potentially costly secondary 
consultations (Wilson et al., 2004). IBS contributes to lost working hours and productivity 
(Dean et al., 2005; Hungin et al., 2005; Wilson et al., 2004) and impacts negatively on 
multiple facets of quality of life including sleep, diet, sexual function, and travel (Amouretti 
et al., 2006; Dancey & Backhouse, 1993; Dancey, Hutton-Young, Moye, & Devins, 2002; 
Faresjö et al., 2006; Lea & Whorwell, 2001).  Additionally, symptoms may result in 
significant emotional distress and those affected may “catastrophise” IBS symptoms as being 
indicative of a potentially life-threatening health condition (Lackner, Quigley, & Blanchard, 
2004; Tanaka, Kanazawa, Fukudo & Drossman., 2011). These issues highlight the need for 
effective treatment for IBS. 
    
The aetiology of IBS is not fully understood and is currently linked to a complex interplay of 
biological and psychosocial factors (Tanaka et al., 2011). Consequently conventional medical 
treatment for IBS is often pharmacologically orientated towards symptom relief rather than 
directed towards potential aetiological factors (Chey, Maneerattaporn, & Saad, 2011; Harris 
& Heitkemper, 2012). Nevertheless, conventional medical treatment is frequently reported as 
unsatisfactory (Hayee & Forgacs, 2007) and considered limited given the scope of IBS 
symptoms. Many opt to use complementary and alternative medicine (CAM) in an effort to 
manage symptoms (Kong et al., 2005).  
 
Complementary and Alternative Medicine Use in IBS 
CAM includes primarily self-funded treatments or therapies that operate on different 
philosophical principles from those of the biomedical model of conventional medicine 
(Zollman & Vickers, 1999). CAM’s prevalence for IBS has been reported between 37 and 
50% (Drossman et al., 2009; Kong et al., 2005; Langmead, Chitnis, & Rampton, 2002) with 
similar rates reported for inflammatory bowel disease (IBD) (Hilsden, Verhoef, Rasmussen, 
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Porcino, & DeBruyn, 2011; Langmead et al., 2002). Demographically, CAM-users are more 
likely to be female, have a greater disposable income, higher educational attainment and 
chronic health conditions with prolonged symptom discomfort (Astin, 1998; Bishop & 
Lewith, 2010; Metcalfe, Williams, McChesney, Patten, & Jetté, 2010; Talley, Boyce, & 
Jones, 1997).   
 
The prevalence of CAM use presents a number of issues for those who practise conventional 
medical treatment of IBS. Firstly, CAM use may indicate that conventional medical care is 
not meeting patient treatment expectations, which may consist of either real or perceived 
shortcomings in medical care (Drossman et al., 2009; Smart, Mayberry, & Atkinson, 1986).  
Secondly, there is potential for harmful interactions between conventional pharmacologic 
treatment and some forms of CAM (Leung, Shalansky, Lo, & Jadusingh, 2009; Shane-
McWhorter & Geil, 2002; Vincent & Furnham, 1997). Thirdly, many CAM treatments for 
IBS currently lack established efficacy (Ford et al., 2008). In the UK, for example, National 
Institute for Health and Clinical Excellence’s guidelines for medical practitioners do not 
recommend the use of acupuncture or reflexology in IBS patients (NICE, 2008).   Clearly 
issues with both conventional medical and CAM treatments exist. One further option for 
management of symptoms is to incorporate psychological factors into treatment protocol.   
 
The Role of Psychological Factors in IBS Management 
The role of psychological factors in IBS has been emphasised by the lack of aetiological 
consensus and conjecture that disturbance in the pathways between brain and gut results in 
IBS symptoms (Quigley, 2006). Evidence indicates that psychological factors related to 
illness, such as perceptions about illness, are important as they may impact on coping 
behaviours and quality of life (Hagger & Orbell, 2003; Rutter & Rutter, 2002), illness 
experience and conventional healthcare seeking (Lea & Whorwell, 2004; van Dulmen, 
Fennis, Mokkink, van der Velden, & Bleijenberg, 1994, 1997; van Dulmen, Fennis, 
Mokkink, & Bleijenberg, 1996).   
 
Future healthcare seeking and anxiety have been shown to be reduced by following an 
intervention directed towards changing specific components of illness perceptions 
(Oerlemans, van Cranenburgh, Herremans, Spreeuwenberg, & van Dulmen, 2010; van 
Dulmen et al., 1996).  Information-based interventions have demonstrated benefits in 
symptom and anxiety reduction and improvements in quality of life through enhanced 
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feelings of control and understanding of IBS (Jarrett et al., 2009; Ringström et al., 2010; 
Robinson et al., 2006). Illness related anxiety may also be reduced by giving a diagnosis of 
IBS (Hayee & Forgacs, 2007; Ilnyckyj, Graff, Blanchard, & Bernstein, 2003). Addressing 
such components could potentially be incorporated into conventional medical consultations to 
aid effective management of IBS symptoms (e.g. van Dulmen et al., 1997). 
   
Psychological influences on CAM use 
Beliefs and perceptions related to illness, treatment and healthcare have been implicated as 
factors important in CAM use. Concerns with efficacy of conventional medical treatment and 
dissatisfaction with doctor-patient communication have influenced CAM use in general 
(Bishop, Yardley, & Lewith, 2006; Horne, Weinman, & Hankins, 1999) and gastro-intestinal 
(GI) populations (Hilsden, Scott, & Verhoef, 1998; Scott, Verhoef, & Hilsden, 2003).  
General population studies have shown illness perceptions influence use of CAM (Bishop et 
al., 2006; Bishop, Yardley, & Lewith, 2007; Searle & Murphy, 2000) and CAM-users have 
been shown to report worse health status (Bishop & Lewith, 2010), and in those affected by 
IBS, poorer quality of life (van Tilburg et al., 2008) than those not using CAM. CAM use 
may be further facilitated by a positive attitude towards CAM (Astin, 1998; Vincent & 
Furnham, 1996). Similarly, when GI patients’ perceived benefits of CAM use (i.e. decreased 
stress, anxiety and pain) outweigh perceived costs (i.e. financial outlay) CAM use is more 
likely (Giese, 2000). These findings suggest CAM-users may report differing beliefs and 
perceptions compared to those not using CAM. Therefore, synthesis of existing findings 
regarding influences on CAM use in IBS may be used to inform the practitioner-client 
consultation and direct the development of psychological components of management 
strategies for this complex and often intractable condition.   
 
Aim of the Review 
The aims of the review were to quantify the extent of CAM use and explore psychological 
factors associated with CAM uptake in those affected by IBS.    
 
Method 
Search Strategy 
Electronic searches were conducted for articles published from 1978 onwards, when the 
Manning diagnostic criteria were published (Manning, Thompson, Heaton, & Morris, 1978).  
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Five electronic databases were searched to identify studies that examined the prevalence of 
and factors that influence CAM use in IBS. These included AMED, EMBASE, Cinahl, 
PubMed, and PsychINFO databases. The Cochrane database for systematic reviews was also 
searched.  Searching was conducted using the terms “irritable bowel syndrome”, 
“complementary” and “alternative”. Further searches were carried out using the terms 
“functional gastrointestinal” and “functional bowel” in conjunction with the terms previously 
listed. Search terms are listed in Figure 1. 
 
Selection process and data analysis 
One researcher (LU) conducted initial searches and selection of abstracts. Duplicates were 
removed from the search and all abstracts subsequently read. Where it was unclear if a study 
fitted the review criteria, the full text was obtained. There were two main inclusion criteria. 
Firstly, studies had to include measurement regarding the extent of CAM use in IBS. 
Secondly, included studies needed to have examined psychological factors that influence 
CAM use in those affected by IBS (such as beliefs about treatment for IBS). No restrictions 
were placed on the type of analysis or design studies used and only studies published in 
English were included. Studies that focused exclusively on conventional care seeking or 
organic bowel conditions were excluded from the review. Reference lists of obtained articles 
were also checked for relevant studies. Two researchers (KM & PF), then cross-validated the 
final selection of studies from the 13 full text articles down to the final five that were 
included. Agreement to include the studies amongst the three researchers was unanimous. 
The process of identification of studies is presented in Figure 2.       
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Figure 1.  Review Search Terms and Strategy 
 
1. Irritable Bowel syndrome (all fields). 
2. Functional Bowel (all fields). 
3. Functional Gastrointestinal (all fields). 
4. Complementary (all fields). 
5. Alternative (all fields). 
6. 1 or 2 or 3. 
7. 6 and 4. 
8. 6 and 5. 
 
Figure 2. Flow Chart Showing the Process of Identifying Relevant Studies  
 
 
n = 1264 potentially relevant 
studies identified from databases  
n= 215 studies examined in greater 
detail for inclusion  
8 Studies excluded: focus on IBD 
or conventional care seeking  
Citations excluded: 202 
commentaries, reviews, pediatric 
samples and duplicates excluded    
1049 studies not focusing on aims 
of review excluded  
n = 5 Studies included in analysis  
n = 13 possible studies to include in 
analysis (obtained in full)  
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Results 
Five studies met the inclusion criteria. Studies were conducted in the UK (Smart et al., 1986), 
Holland (Donker, Foets, & Spreeuwenberg, 1999), Canada (Verhoef, Sutherland, & Brkich, 
1990), Australia (Koloski, Talley, Huskic, & Boyce, 2003) and the US (van Tilburg et al., 
2008). Four studies used a survey/questionnaire design and one (Donker et al., 1999) used 
quantifiable structured interviews. A summary of findings is provided in Table 2. 
 
Included studies focused on participants with a functional bowel disorder (FBD, referring to 
IBS) or made sole reference to IBS. Recruitment and data collection varied from postal 
questionnaires (Smart et al., 1986), to recruitment from a general practitioner clinic (Donker 
et al., 1999) and outpatient clinic (Smart et al., 1986; Verhoef et al., 1990). Two studies used 
data collected from previous work by the respective authors, for example from a previous 
healthcare survey for those with FBD (van Tilburg et al., 2008), and previous population 
surveys (Koloski et al., 2003). The studies reported female predominance in samples, ranging 
from 60 to75%. 
 
Study Methodologies 
All studies examined group differences. Two studies (van Tilburg et al., 2008; Verhoef et al., 
1990) used one group of IBS/FBD outpatients and analysed participants in terms of those 
who had used or not used CAM. Smart et al. (1986) compared 96 IBS patients to 143 patients 
with other unspecified organic upper GI disorders and 222 Crohn’s disease patients. Donker 
et al. (1999) and Koloski et al. (2003) compared an IBS group to healthy controls in addition 
to healthcare (including alternative healthcare) consulters and non-consulters.     
 
Smart et al. (1986) assessed the frequency of CAM use in patients with a diagnosis of IBS 
according to the Manning criteria (Manning et al., 1978) and for whom a clinical examination 
revealed no bowel abnormalities. Patients with organic GI disorders were recruited from the 
same outpatient clinic as those with IBS and Crohn’s patients were contacted via post. All 
participants completed a questionnaire on alternative medicine consultations. Verhoef et al. 
(1990) however, examined patients who sought alternative treatment for the problem which 
had required a consultation with a GI specialist in the past two years. Differences in 
demographic profile and health status between CAM users and non-users were compared. Of 
the 395 GI patients recruited, 55 were classified as having a functional GI disorder with 
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diagnosis made by four GI specialists. This study excluded patients who used CAM for 
health problems other than their diagnosed GI disorders. Participants completed a three item 
index based on scepticism towards conventional medicine and were asked about alternative 
medicine use during the previous two years. 
 
Donker et al. (1999) focused on the health status of 53 patients with IBS recruited from 
general practices participating in the Dutch National Survey of Morbidity and Intervention in 
General Practice and compared their use of healthcare services including CAM to a 
population sample of 10787. Participants were asked about healthcare use, health problems in 
the two weeks prior to being questioned and completed the General Health Questionnaire 
(GHQ) a screening tool for psychiatric illness (Goldberg, 1972) and the biographic problem 
list (BIOPRO) which measured social problems (Hosman, 1983). Health related behaviour 
(e.g. smoking, exercise) and the amount of healthcare sought was also measured which 
ranged from seeing a doctor (previous three months), a physical therapist (previous 12 
months), a specialist (last two years) and an alternative therapist (previous five years). 
 
Using semi-structured interviews and questionnaires, Koloski et al. (2003) considered usage 
of both conventional and alternative healthcare in 207 patients with functional GI diagnoses 
(IBS or functional dyspepsia). Participants were recruited from one of two previous surveys 
carried out by the authors and separated into consulters or non-consulters for both 
conventional and alternative healthcare. Participants were asked about frequency, access and 
satisfaction with healthcare. The structured interview for bowel symptoms was administered 
to give a functional diagnosis based on the Rome I criteria (Drossman et al., 1994). This 
structured interview also accounted for aspects related to quality of life and extent of 
symptoms. In addition, participants were given the Composite International Diagnostic 
Interview (World Health Organisation, 1997) designed to assess past and current 
psychological disturbance. 
 
Using data from 1012 FBD patients recruited from an “outpatient” healthcare maintenance 
organisation in a previous study (Nyrop et al., 2007), van Tilburg et al. (2008) examined 
CAM use in IBS and FBD. Participants were assessed for symptom severity at a “baseline” 
visit to the clinic with the Irritable Bowel Syndrome Severity Scale (IBS-SS) (Francis, 
Morris, & Whorwell, 1997), quality of life using the Irritable Bowel Syndrome Quality of 
10 
 
Life scale, IBS-QOL (Patrick et al., 1998), psychological distress using the Brief Symptom 
inventory (BSI) (Derogatis, 1993), perceived treatment effectiveness, and CAM use.   
 
Extent of CAM Use  
The reviewed studies indicated CAM use at between 9 and 38.4%. Smart et al. (1986) found 
significantly more of those with IBS had visited an alternative practitioner compared to 
Crohn’s and organic GI patients. Current alternative medicine use was significantly greater in 
the IBS group and herbal treatments and homeopathy were used most frequently (Smart et al., 
1986). Verhoef et al. (1990) reported that 50% of CAM-users had FBD (compared to 13% of 
non-CAM users) and 9% used CAM for the condition they presented to a gastroenterologist.  
Chiropractors (for conditions other than GI), herbalists, naturopaths and reflexologists were 
that most frequently CAM practitioners and 46% of participants had visited more than one 
type of CAM practitioner.   
 
Donker et al. (1999) found the IBS patient group had paid significantly more visits to an 
alternative practitioner than the population group (32% compared with 15%). Koloksi et al. 
(2003) revealed that 86.5% of the functional GI group had sought conventional healthcare at 
some point, and a reported 20.8% of participants had sought alternative healthcare, with only 
9% using any CAM in the previous 12 months.  The most frequently accessed treatment was 
naturopathy. Van Tilburg et al. (2008) found 35% of those with FBD and 38.4% of those 
with IBS had used CAM with ginger, massage therapy and yoga being the most frequently 
used treatments. 
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Table 2  
Summary of Studies Included in the Review 
First author, 
Year, Country 
 
Participants Diagnosis of 
IBS 
Outcomes Extent of CAM use Reasons for CAM use 
Smart et al. 
(1986)  
(UK) 
n = 96 IBS patients 
(n = 67 female); n 
=143 organic GI (n 
= 84 female); n = 
222 Crohn’s 
disease (n = 137 
female). 
 
IBS - 
Manning et al. 
(1978). 
Questionnaire – 
practices and 
practitioners.  No. of 
treatments, treatment 
options. 
CAM use: IBS (11%); 
GI (4%); Crohn’s (6%). 
Consulted CAM 
practitioner: IBS 
(16%); GI (2%); 
Crohn’s (6%).  
 
CAM use significantly more likely if 
conventional treatment “had failed” 
in those with IBS. 
 
Verhoef et al. 
(1990) 
(Canada) 
n = 395 GI adult 
outpatients (n = 237 
female) 
(n = 63 Functional 
diagnosis) 
Gastroenterol
ogist 
consensus 
scale 1 
(functional) – 
5 (organic). 
 CAM use and 
scepticism towards 
conventional medicine 
index. 
50% of CAM-users had 
functional diagnoses 
(13% of non users).   
41% of CAM use not 
for bowel disorder but 
other health issue. 
 
 
CAM-users significantly less 
satisfied with conventional treatment 
(54% vs. 85% non-users); had more 
stressful life events in previous year 
(70% vs. 47%); more sceptical of 
conventional medicine (49% vs. 
13%) and less satisfied with 
conventional practitioner answers 
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(77% vs. 91%). 
 
 
 
Donker et al. 
(1999) 
(Holland) 
 
 
 
n= 10787 GP 
registered (age 15+, 
51% female) n = 53 
(n = 37 female) IBS 
patients via General 
practice. 
 
Diagnosed 
prior to study. 
Questionnaire – 
experienced health; 
GHQ (30); no. of 
complaints (14 days 
prior); BIOPRO scale 
(n = 53 interviews). 
32% of those with IBS 
consulted CAM 
practitioner (15% non-
IBS). 
IBS patients had significantly poorer 
health (and “other” complaints); 
higher GHQ and BIOPRO scores 
compared to population group.   
 
 
Koloski et al. 
(2003) 
(Australia) 
n = 207 IBS/FD 
patients (n = 143 
female); n = 100 
controls (no. 
symptoms – not 
included in all 
analyses). 
Abdominal 
pain > 1 
month; Rome 
I criteria.  IBS 
or functional 
dyspepsia. 
Healthcare seeking 
SSI; symptom status; 
Psychological 
morbidity. 
86.5% functional GI 
group sought 
conventional 
healthcare. 20.8% had 
sought alternative 
healthcare. 9% had 
used CAM in previous 
12 months. 
 
 
Females significantly more likely to 
use CAM in contrast to greater pain 
and perception of symptoms 
predicting conventional care 
seeking. 
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Note:    BIOPRO - Biographical list of problems; BSI - Brief Symptom Inventory; GHQ - General Health Questionnaire; IBS-QOL – Irritable Bowel Syndrome Quality of 
Life; IBS-SS – IBS symptom severity scale; SSI – Semi-structured interview 
 
 
                          
 
 
 
 
 
van Tilburg et 
al. (2008) 
(US) 
n = 1012 patients 
with IBS or other 
functional diagnosis  
(n = 248 male).  
CAM-users and 
non-CAM users 
compared. 
Patient index 
cards 
screened to 
determine IBS 
or other 
functional 
diagnosis. 
Set of questionnaires 
including: symptom 
severity (IBS-SS); 
Quality of life (IBS-
QOL); Psychological 
distress (Brief 
symptom inventory – 
BSI); Ratings of 
perceived effectiveness 
of treatment. 
CAM use was 35% 
over past three months 
in FBD, 38% in IBS; 
ginger, massage and 
yoga were the most 
popular CAM 
treatments. 
Factors that predicted CAM use 
were being female, higher education 
level and higher anxiety (BSI).  
Dissatisfaction with conventional 
care and perception of lack of 
effectiveness of prescription 
medication were not associated with 
CAM use. 
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Reasons for CAM Use 
Demographics and Functional Diagnosis  
Koloski et al. (2003) found 88.4% of the 20.8% of CAM users were female. However, 79.8% 
of participants (64% who were female) did not use alternative healthcare. Neither Donker et 
al. (1999), Smart et al. (1986) or Verhoef et al. (1990) specifically examined the role of 
gender although Donker et al. (1999) reported that a majority of IBS patients were female.  
Van Tilburg et al. (2008) found being female and higher educational attainment predicted 
CAM use. Verhoef et al. (1990) reported that a functional diagnosis was an independent 
predictor of CAM use compared to those with organic GI disorders. Similarly, Smart et al. 
(1986) reported more patients with IBS than Crohn’s used CAM.   
 
Perception of Symptoms  
Donker et al. (1999) found significantly more IBS outpatients used CAM than the population 
group and those with IBS reported significantly more intense symptoms (e.g. abdominal pain 
and “secondary” symptoms including tiredness, backache and headaches). Koloski et al. 
(2003) found that physical symptoms of IBS significantly predicted conventional care 
seeking rather than CAM use. Van Tilburg et al. (2008) found stronger perceptions of 
symptom severity were associated with CAM use but not when controlling for demographics 
and other variables (e.g. the IBS-QOL and IBS-SS) in a logistic regression model. 
 
Patient Perception of Conventional Treatment 
Smart et al. (1986) found that the IBS group were more likely to report using alternative 
treatments if they perceived conventional treatment had failed. Verhoef et al. (1990) observed 
that 54% of CAM-users with GI disorders (including IBS) were satisfied with conventional 
treatment compared with 85% of non-CAM participants and that GI patients who used CAM 
were significantly more sceptical (49%) of conventional medicine than those not using CAM 
(13%). Verhoef et al. (1990) also revealed associations between a functional diagnosis and 
scepticism towards conventional medicine, and that these variables both (independently) 
significantly predicted the use of CAM.  In relation to communication between conventional 
practitioner and patient, CAM-users were less satisfied with responses from conventional 
practitioners than non-CAM users (77% vs 91%). Koloski et al. (2003) found dissatisfaction 
did not significantly influence CAM use, although there was some difference between CAM-
users and non-CAM users. Van Tilburg et al. (2008) found no association between CAM use 
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and satisfaction with physician care during their primary visit and that CAM-users did not 
rate their conventional prescription medication as being less effective than non-CAM users.  
 
Beliefs about CAM Treatments and Therapies 
One study reported expectations of CAM efficacy as a rationale for IBS patients to use CAM.  
Koloski et al. (2003) found a desire to treat the GI problem with a more natural approach, the 
potential for alternative treatments to work and personal recommendation were all factors 
(albeit not significant) that appear to influence CAM use. Donker et al. (1999) reported that 
92% of CAM-users felt CAM had helped.   
 
Other Psychosocial Factors 
Verhoef et al. (1990) found stressful life events in the previous year significantly predicted 
CAM use in those with FBD. Donker et al. (1999) reported that those with IBS had higher 
scores on the GHQ than the population group. Differences were observed in the two groups’ 
BIOPRO scores where those with IBS reported greater concerns about the future, lower self-
confidence, fewer social interactions, and relationship difficulties.  The IBS group reported 
more occupational absence in the two months prior to the study.  Additionally, having IBS 
resulted in significantly more visits to the family GP, a physical therapist and a GI specialist.  
The significant differences observed in healthcare seeking (including CAM use) between the 
two groups may be influenced by such psychosocial factors (Donker et al., 1999). Koloski et 
al. (2003) observed differences, albeit not significant, between both sets of healthcare 
consulters (CAM and conventional treatment) and non-consulters in psychological 
disturbance and perception of symptoms. Van Tilburg et al. (2008) found CAM-users 
reported significantly poorer IBS-QOL scores compared to those not using CAM. CAM-users 
also reported higher scores on the somatisation, anxiety and depression subscales of the 
BSI.Logistic regression analysis revealed that anxiety was the sole significant psychosocial 
predictor of CAM use.   
 
Discussion 
Prevalence of CAM was lower than CAM use reported by Kong et al. (2005) and Langmead 
et al. (2002). However, this might be explained by reviewed studies focusing on consultation 
with a CAM practitioner as opposed to self-directed treatments (Kong et al., 2005). The 
reviewed studies included patient group and healthy control population comparisons, in 
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addition to comparisons of those with IBS who used CAM and those not using CAM.  
Findings indicate that those with IBS who use CAM may report more severe symptoms and 
have concerns about conventional medicine including unhappiness and dissatisfaction with 
conventional care. 
 
Female predominance was evident, which is concurrent with what is known about IBS (e.g. 
Andrews et al., 2005), however, in terms of CAM, there was limited agreement with findings 
from non-illness specific investigation into CAM use. CAM use in general has been reported 
to have female predominance (e.g. Astin, 1998), although only one reviewed study (van 
Tilburg et al., 2008) found that being female was an independent predictor of CAM use in 
those with a functional GI diagnosis. It should be noted however that the reviewed studies 
had a predominantly female representation which is consistent with previous findings that a 
greater proportion of females than males seek healthcare for IBS/functional GI symptoms 
(Andrews et al., 2005; Hungin et al., 2005).  It has yet to be ascertained whether this disparity 
between males and females is due to biological or environmental distinctions related to 
gender or might be explained by differences in healthcare seeking (Corazziari, 2004). 
 
Although there has been limited examination of many psychological aspects in general 
populations of CAM-users, points of contrast and similarity exist with what is currently 
known about possible psychological influences on CAM use. Illness related perceptions, for 
example, were not found to be strong influences on CAM use. This is in contrast to findings 
from Bishop et al. (2006) who found stronger perceived consequences of illness (from a 
general population) predicted use of CAM. This finding may be more indicative of a lack of 
measurement of such constructs. With illness perceptions being a key component for 
intervention in IBS (e.g. Oerlemans et al., 2010) this represents one important aspect that 
could be addressed by future research. CAM-users however, reported poorer quality of life 
and more severe symptoms, which concurs to an extent with Astin (1998) who established 
CAM-users from a general population reported poorer health than those not using CAM.  
There are further similarities in CAM-users affected by IBD who report amplified symptom 
perception and poorer quality of life (Hilsden et al., 1998; Langmead et al., 2002; Scott et al., 
2003). One study (Koloski et al., 2003) found increased perception of IBS symptoms 
predicted conventional care seeking suggesting it worthwhile to investigate this further in 
relation to use of CAM. 
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Treatment related beliefs however, appeared more influential on CAM use than illness 
perceptions.  For example, findings showed a negative perception of conventional medical 
care influenced CAM use as did a desire to treat GI symptoms with a more natural approach 
(Bishop et al., 2006; Vincent & Furnham, 1996). A degree of dissatisfaction with 
conventional medicine also appears evident, as found by Scott et al. (2003) in IBD patients.  
However, future research should clarify whether this is due to issues with conventional 
treatment itself and the healthcare consultation, or both factors.   
 
A major strength of this review is that it is the first to synthesise both prevalence estimates 
and evidence of why people affected with IBS use CAM. Several psychological factors that 
have a role in influencing CAM use have been highlighted. These findings may be beneficial 
in informing areas of potential intervention in conventional medical consultations. The 
review further highlights the paucity of research in this important area, thus highlighting the 
need for additional research that would aid understanding of influences on CAM use. This 
review has identified specific areas of investigation that could be addressed by future 
research. This may include addressing specific psychological components of illness and 
treatment beliefs and assessing potential influence of these factors on CAM use in those 
affected by IBS. Furthermore, exploring aspects of the health practitioner-client relationship 
to determine where dissatisfaction may arise could have potential benefits in targeting and 
implementing future improvements in healthcare.    
 
Conversely this review has a number of limitations that need to be considered. Due to 
differences in sample size and measures used in the selected studies, meta-analysis was not 
deemed appropriate due to variation in both study design and reporting of findings.  
However, across the five reviewed studies, there were common themes why those with IBS 
turn to CAM although the methodological variation in the studies makes generalisation of 
findings problematic and potentially limited. Group comparisons in each study differed 
notably and it might be suggested that a protocol of studying CAM-users compared with 
those not using CAM may be advantageous in terms of explaining psychological influences 
on CAM use more precisely. There may also be benefit in examining factors that pull people 
to different forms of CAM (Bishop et al., 2006) as findings suggested that CAM is, at least 
partially, sometimes viewed as a single entity in terms of treatment. The reviewed studies 
were also conducted in different countries where differences in healthcare service provision 
may exist in addition to cultural differences. Furthermore, there was variation in participant 
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numbers in each of the studies. Two studies for example (Donker et al., 1999; Verhoef et al., 
1990) had relatively small numbers of participants with IBS/FBD. There is some ambiguity 
concerning the scope of functional GI diagnosis (Verhoef et al., 1990) and if all participants 
had IBS or different functional diagnoses (such as functional dyspepsia) (Koloski et al., 
2003).   
 
It was notable that none of the reviewed studies considered emotional response to illness, 
something that is often a concern in those with IBS (e.g. Tanaka et al., 2011). CAM use was 
however predicted by higher reported anxiety in one study (van Tilburg et al., 2008) but it is 
unclear if anxiety was present pre or post-illness. The psychosocial factors (e.g. BIOPRO 
responses) reported by Donker et al. (1999) in the IBS group warrant further investigation as 
this particular study focused on a small group of those affected by IBS and a considerably 
larger population group. Further longitudinal investigation may reveal the extent to which 
these factors influence CAM use and if differences exist on such constructs between CAM-
users and those not using CAM. Additionally, there were notable differences in the 
measurement of symptom experience. Smart et al. (1986) did not consider symptom duration 
important in predicting CAM use in IBS as more patients with IBS were currently using 
CAM than the Crohn’s group (who have similar symptoms). Two studies (Donker et al., 
1999; van Tilburg et al., 2008) considered the severity of GI symptoms and one considered 
ratings of quality of life (van Tilburg et al., 2008). Verhoef et al. (1990) however, did not 
consider participants’ reported symptoms. Further investigation into perceived severity of 
IBS symptoms is therefore warranted to determine if CAM-users report more severe IBS 
symptoms. 
 
Furthermore in relation to concerns about conventional medical treatment, “failure” of (Smart 
et al., 1986) and “dissatisfaction” with conventional treatment (Koloski et al., 2003) may 
reflect sub-dimensions of the same construct. Both refer to treatment, the consultation or 
both.  In the studies reviewed, measurement of these factors varied considerably. Koloski et 
al. (2003) conducted a healthcare seeking interview while Smart et al. (1986) asked 
specifically about failure of conventional treatment. Verhoef et al. (1990) assessed scepticism 
towards conventional medicine. Van Tilburg et al. (2008) considered first healthcare visits 
and perceived effectiveness of prescription medication. Moreover, four studies (Donker et al., 
1999; Koloski et al., 2003; Smart et al., 1986; Verhoef et al., 1990) focused solely on CAM 
consultations thus neglecting “off the shelf” products from the analysis. Clarification of the 
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nature of dissatisfaction and a more expansive inclusion of CAM, which would include self-
purchased treatments and consideration of different forms of CAM, are additional factors that 
could be addressed in future research.   
 
Conclusion and implications 
CAM’s use has been shown to be associated with psychological factors which could be 
targeted through psychologically based management strategies for those affected with IBS.  
Such interventions may be beneficial in addressing negative symptom or treatment 
perceptions and emotional distress that may accompany IBS symptoms (e.g. van Dulmen et 
al., 1996) in addition to focusing on providing information about IBS (e.g. Jarrett et al., 
2009). It is possible that CAM-users may initially benefit more from such intervention as 
evidence suggests those with IBS using CAM report an amplified or more intense illness 
experience than those not using CAM. This may extend to CAM-users reporting poorer 
quality of life despite using CAM although future longitudinal studies are required to support 
this. The array of psychological factors identified by this review also suggests that the 
application of a theoretical framework to future research may aid understanding and inform 
translation to practical interventions. One such model, the common-sense model of illness 
representation (Leventhal, Brissette, & Leventhal, 2003) has incorporated both illness 
perceptions and treatment beliefs (e.g. Bishop et al., 2006). This model has had success in 
both exploration and translation of findings into practical change in illness perceptions 
resulting in benefits to health (McAndrew et al., 2008). 
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